EC gives nod for Clinigen to update Cardioxane advice
Clinigen Group
925.00p
16:39 04/04/22
0.00%
0.00p
Global pharmaceutical and services company Clinigen Group announced on Thursday that its commercial medicines operation has received European Commission approval to update the current product information for Cardioxane.
Food & Drug Retailers
4,013.60
16:54 03/05/24
0.17%
6.81
FTSE AIM 100
3,724.78
17:14 03/05/24
n/a
n/a
FTSE AIM 50
4,045.34
17:14 03/05/24
n/a
n/a
FTSE AIM All-Share
771.53
17:14 03/05/24
n/a
n/a